Showing results (2261-2270 of 8,948) with videos related to

Sort By:
Pageof 895
Schizophrenia Research|July 28, 2010
Common variants conferring risk of schizophrenia: a pathway analysis of GWAS dataPeilin Jia, Lily Wang, Herbert Y Meltzer, et al.
Schizophrenia Research|May 15, 2010
Association of NPAS3 exonic variation with schizophreniaGeorgina Macintyre, Tyler Alford, Lan Xiong, et al.
Schizophrenia Research|September 14, 2010
The role of the insula in schizophreniaKorey P Wylie, Jason R Tregellas
Schizophrenia Research|September 7, 2010
Impaired insight in patients with newly diagnosed nonaffective psychotic disorders with and without deficit featuresHanan D Trotman, Brian Kirkpatrick, Michael T Compton
Schizophrenia Research|September 22, 2010
Clinical significance of neurological soft signs in schizophrenia: factor analysis of the Neurological Evaluation ScaleR Andrew Sewell, Edward B Perry, Laurence P Karper, et al.
Schizophrenia Research|September 21, 2010
Prevalence of metabolic syndrome among patients with schizophrenia in JapanNorio Sugawara, Norio Yasui-Furukori, Yasushi Sato, et al.
Schizophrenia Research|September 21, 2010
Increased parahippocampal and lingual gyrification in first-episode schizophreniaC Christoph Schultz, Kathrin Koch, Gerd Wagner, et al.
Schizophrenia Research|September 10, 2010
Cannabis use and cognitive functioning in first-episode schizophrenia patientsJosé Manuel Rodríguez-Sánchez, Rosa Ayesa-Arriola, Ignacio Mata, et al.
Schizophrenia Research|September 11, 2010
Cognitive and symptomatic predictors of functional disability in schizophreniaSyed Shamsi, Adam Lau, Todd Lencz, et al.
Schizophrenia Research|June 24, 2010
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatmentNorbert Müller, Daniela Krause, Sandra Dehning, et al.
Pageof 895